Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Class Sues Intermune CEO Over Lung Drug

SAN FRANCISCO (CN) - Intermune and Genentech defrauded the public of millions of dollars by pushing the drug Actimmune for idiopathic pulmonary fibrosis, through misrepresentations, and Intermune CEO W. Scott Harkonen was criminally indicted for his role in it, according to a RICO class action in Federal Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...